Rini Life Science is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $1.1M of exports covering 89 molecules to 20 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Chlorzoxazone | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $88K | 3 |
| 2025 | Not reported | $1.1M | 20 |
| 2024 | Not reported | $1.1M | 14 |
| 2023 | Not reported | $1.2M | 13 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Rini Life Science comes back tiered against every other supplier able to file there.
Start for free